Selected research
Industry Growth & Trends
Global Peptide Synthesis CDMO Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Peptide Synthesis CDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Peptide Synthesis CDMO Services market include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Peptide Synthesis CDMO Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Peptide Synthesis CDMO Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Synthesis CDMO Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Synthesis CDMO Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Peptide Synthesis CDMO Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Peptide Synthesis CDMO Services Market by Company
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem
Peptide Synthesis CDMO Services Segment by Type
GMP Services
Non-GMP Services
Peptide Synthesis CDMO Services Segment by Application
Commercial
Scientific Research
Other
Peptide Synthesis CDMO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis CDMO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Peptide Synthesis CDMO Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Global Peptide Synthesis CDMO Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032
Table 2. Global Peptide Synthesis CDMO Services Market Size by Region (2021-2026) & (US$ Million)
Table 3. Global Peptide Synthesis CDMO Services Market Share by Region (2021-2026)
Table 4. Global Peptide Synthesis CDMO Services Market Size by Region (2027-2032) & (US$ Million)
Table 5. Global Peptide Synthesis CDMO Services Market Share by Region (2027-2032)
Table 6. Global Peptide Synthesis CDMO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 7. Global Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 8. Global Peptide Synthesis CDMO Services Market Size Share by Type (2021-2026)
Table 9. Global Peptide Synthesis CDMO Services Market Size Forecasted by Type (2027-2032) & (US$ Million)
Table 10. Global Peptide Synthesis CDMO Services Market Size Share Forecasted by Type (2027-2032)
Table 11. North America Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 12. North America Peptide Synthesis CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 13. Europe Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 14. Europe Peptide Synthesis CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 15. Asia-Pacific Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 16. Asia-Pacific Peptide Synthesis CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 17. Latin America Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 18. Latin America Peptide Synthesis CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 19. Middle East and Africa Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 20. Middle East and Africa Peptide Synthesis CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 21. Global Peptide Synthesis CDMO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 22. Global Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 23. Global Peptide Synthesis CDMO Services Market Size Share by Application (2021-2026)
Table 24. Global Peptide Synthesis CDMO Services Market Size Forecasted by Application (2027-2032) & (US$ Million)
Table 25. Global Peptide Synthesis CDMO Services Market Size Share Forecasted by Application (2027-2032)
Table 26. North America Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 27. North America Peptide Synthesis CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 28. Europe Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 29. Europe Peptide Synthesis CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 30. Asia-Pacific Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 31. Asia-Pacific Peptide Synthesis CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 32. Latin America Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 33. Latin America Peptide Synthesis CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 34. Middle East and Africa Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 35. Middle East and Africa Peptide Synthesis CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 36. Peptide Synthesis CDMO Services Industry Trends
Table 37. Peptide Synthesis CDMO Services Industry Drivers
Table 38. Peptide Synthesis CDMO Services Industry Opportunities and Challenges
Table 39. Peptide Synthesis CDMO Services Industry Restraints
Table 40. Global Peptide Synthesis CDMO Services Revenue by Company (US$ Million) & (2021-2026)
Table 41. Global Peptide Synthesis CDMO Services Revenue Market Share by Company (2021-2026)
Table 42. Global Peptide Synthesis CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026
Table 43. Global Peptide Synthesis CDMO Services Key Company Headquarters & Area Served
Table 44. Global Peptide Synthesis CDMO Services Company, Product Type & Application
Table 45. Global Peptide Synthesis CDMO Services Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Peptide Synthesis CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 48. Bachem Company Information
Table 49. Bachem Business Overview
Table 50. Bachem Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 51. Bachem Peptide Synthesis CDMO Services Product Portfolio
Table 52. Bachem Recent Development
Table 53. CordenPharma Company Information
Table 54. CordenPharma Business Overview
Table 55. CordenPharma Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 56. CordenPharma Peptide Synthesis CDMO Services Product Portfolio
Table 57. CordenPharma Recent Development
Table 58. PolyPeptide Company Information
Table 59. PolyPeptide Business Overview
Table 60. PolyPeptide Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 61. PolyPeptide Peptide Synthesis CDMO Services Product Portfolio
Table 62. PolyPeptide Recent Development
Table 63. AmbioPharm Company Information
Table 64. AmbioPharm Business Overview
Table 65. AmbioPharm Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 66. AmbioPharm Peptide Synthesis CDMO Services Product Portfolio
Table 67. AmbioPharm Recent Development
Table 68. Genscript Company Information
Table 69. Genscript Business Overview
Table 70. Genscript Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 71. Genscript Peptide Synthesis CDMO Services Product Portfolio
Table 72. Genscript Recent Development
Table 73. Thermo Fisher Company Information
Table 74. Thermo Fisher Business Overview
Table 75. Thermo Fisher Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 76. Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio
Table 77. Thermo Fisher Recent Development
Table 78. USV Peptides Company Information
Table 79. USV Peptides Business Overview
Table 80. USV Peptides Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 81. USV Peptides Peptide Synthesis CDMO Services Product Portfolio
Table 82. USV Peptides Recent Development
Table 83. Bio Basic Company Information
Table 84. Bio Basic Business Overview
Table 85. Bio Basic Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 86. Bio Basic Peptide Synthesis CDMO Services Product Portfolio
Table 87. Bio Basic Recent Development
Table 88. ScinoPharm Company Information
Table 89. ScinoPharm Business Overview
Table 90. ScinoPharm Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 91. ScinoPharm Peptide Synthesis CDMO Services Product Portfolio
Table 92. ScinoPharm Recent Development
Table 93. JPT Company Information
Table 94. JPT Business Overview
Table 95. JPT Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 96. JPT Peptide Synthesis CDMO Services Product Portfolio
Table 97. JPT Recent Development
Table 98. CBL Company Information
Table 99. CBL Business Overview
Table 100. CBL Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 101. CBL Peptide Synthesis CDMO Services Product Portfolio
Table 102. CBL Recent Development
Table 103. Piramal Pharma Company Information
Table 104. Piramal Pharma Business Overview
Table 105. Piramal Pharma Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 106. Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio
Table 107. Piramal Pharma Recent Development
Table 108. CPC Scientific Company Information
Table 109. CPC Scientific Business Overview
Table 110. CPC Scientific Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 111. CPC Scientific Peptide Synthesis CDMO Services Product Portfolio
Table 112. CPC Scientific Recent Development
Table 113. Creative Peptides Company Information
Table 114. Creative Peptides Business Overview
Table 115. Creative Peptides Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 116. Creative Peptides Peptide Synthesis CDMO Services Product Portfolio
Table 117. Creative Peptides Recent Development
Table 118. Chinese Peptide Company Company Information
Table 119. Chinese Peptide Company Business Overview
Table 120. Chinese Peptide Company Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 121. Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio
Table 122. Chinese Peptide Company Recent Development
Table 123. ChengDu ShengNuo Biotec Company Information
Table 124. ChengDu ShengNuo Biotec Business Overview
Table 125. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 126. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio
Table 127. ChengDu ShengNuo Biotec Recent Development
Table 128. AppTec Co., Ltd. Company Information
Table 129. AppTec Co., Ltd. Business Overview
Table 130. AppTec Co., Ltd. Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 131. AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio
Table 132. AppTec Co., Ltd. Recent Development
Table 133. GL Biochem Company Information
Table 134. GL Biochem Business Overview
Table 135. GL Biochem Peptide Synthesis CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 136. GL Biochem Peptide Synthesis CDMO Services Product Portfolio
Table 137. GL Biochem Recent Development
Table 138. North America Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 139. North America Peptide Synthesis CDMO Services Market Size by Country (2021-2026) & (US$ Million)
Table 140. North America Peptide Synthesis CDMO Services Market Share by Country (2021-2026)
Table 141. North America Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 142. North America Peptide Synthesis CDMO Services Market Share Forecast by Country (2027-2032)
Table 143. Europe Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 144. Europe Peptide Synthesis CDMO Services Market Size by Country (2021-2026) & (US$ Million)
Table 145. Europe Peptide Synthesis CDMO Services Market Share by Country (2021-2026)
Table 146. Europe Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 147. Europe Peptide Synthesis CDMO Services Market Share Forecast by Country (2027-2032)
Table 148. Asia-Pacific Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 149. Asia-Pacific Peptide Synthesis CDMO Services Market Size by Country (2021-2026) & (US$ Million)
Table 150. Asia-Pacific Peptide Synthesis CDMO Services Market Share by Country (2021-2026)
Table 151. Asia-Pacific Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 152. Asia-Pacific Peptide Synthesis CDMO Services Market Share Forecast by Country (2027-2032)
Table 153. Latin America Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 154. Latin America Peptide Synthesis CDMO Services Market Size by Country (2021-2026) & (US$ Million)
Table 155. Latin America Peptide Synthesis CDMO Services Market Share by Country (2021-2026)
Table 156. Latin America Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 157. Latin America Peptide Synthesis CDMO Services Market Share Forecast by Country (2027-2032)
Table 158. Middle East & Africa Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 159. Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021-2026) & (US$ Million)
Table 160. Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country (2021-2026)
Table 161. Middle East & Africa Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 162. Middle East & Africa Peptide Synthesis CDMO Services Market Share Forecast by Country (2027-2032)
Table 163. Research Programs/Design for This Report
Table 164. Authors List of This Report
Table 165. Secondary Sources
List of Figures
Figure 1.List of Figures
Figure 2. Peptide Synthesis CDMO Services Product Image
Figure 3. Global Peptide Synthesis CDMO Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 4. Global Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 5. Global Peptide Synthesis CDMO Services Market Share by Region: 2025 VS 2032
Figure 6. Global Peptide Synthesis CDMO Services Market Share by Region (2021-2032)
Figure 7. North America Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 8. Europe Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 9. Asia-Pacific Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 10. Latin America Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 11. Middle East & Africa Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 12. GMP Services Image
Figure 13. Global GMP Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 14. Non-GMP Services Image
Figure 15. Global Non-GMP Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 16. Global Peptide Synthesis CDMO Services Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 17. Global Peptide Synthesis CDMO Services Market Share by Type 2025 VS 2032
Figure 18. North America Peptide Synthesis CDMO Services Market Size Share by Type (2021-2032)
Figure 19. Europe Peptide Synthesis CDMO Services Market Size Share by Type (2021-2032)
Figure 20. Asia-Pacific Peptide Synthesis CDMO Services Market Size Share by Type (2021-2032)
Figure 21. Latin America Peptide Synthesis CDMO Services Market Size Share by Type (2021-2032)
Figure 22. Middle East and Africa Peptide Synthesis CDMO Services Market Size Share by Type (2021-2032)
Figure 23. Commercial Image
Figure 24. Global Commercial Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Scientific Research Image
Figure 26. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Other Image
Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Global Peptide Synthesis CDMO Services Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 30. Global Peptide Synthesis CDMO Services Market Share by Application 2025 VS 2032
Figure 31. North America Peptide Synthesis CDMO Services Market Size Share by Application (2021-2032)
Figure 32. Europe Peptide Synthesis CDMO Services Market Size Share by Application (2021-2032)
Figure 33. Asia-Pacific Peptide Synthesis CDMO Services Market Size Share by Application (2021-2032)
Figure 34. Latin America Peptide Synthesis CDMO Services Market Size Share by Application (2021-2032)
Figure 35. Middle East and Africa Peptide Synthesis CDMO Services Market Size Share by Application (2021-2032)
Figure 36. Global Top 5 and 10 Peptide Synthesis CDMO Services Players Market Share by Revenue in 2025
Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 38. North America Peptide Synthesis CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 39. North America Peptide Synthesis CDMO Services Market Share by Country: 2021 VS 2025 VS 2032
Figure 40. North America Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 41. Europe Peptide Synthesis CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 42. Europe Peptide Synthesis CDMO Services Market Share by Country: 2021 VS 2025 VS 2032
Figure 43. Europe Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 44. Asia-Pacific Peptide Synthesis CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 45. Asia-Pacific Peptide Synthesis CDMO Services Market Share by Country: 2021 VS 2025 VS 2032
Figure 46. Asia-Pacific Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 47. Latin America Peptide Synthesis CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 48. Latin America Peptide Synthesis CDMO Services Market Share by Country: 2021 VS 2025 VS 2032
Figure 49. Latin America Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 50. Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 51. Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country: 2021 VS 2025 VS 2032
Figure 52. Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 53. Years Considered
Figure 54. Research Process
Figure 55. Key Executives Interviewed
Scope & coverage.
Types
- GMP Services
- Non-GMP Services
Applications
- Commercial
- Scientific Research
- Other
Companies covered
- Bachem
- CordenPharma
- PolyPeptide
- AmbioPharm
- Genscript
- Thermo Fisher
- USV Peptides
- Bio Basic
- ScinoPharm
- JPT
- CBL
- Piramal Pharma
- CPC Scientific
- Creative Peptides
- Chinese Peptide Company
- ChengDu ShengNuo Biotec
- AppTec Co., Ltd.
- GL Biochem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Peptide Synthesis CDMO Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Peptide Synthesis CDMO Services Market Size by Region (2021-2032)
- 1.4.1 Global Peptide Synthesis CDMO Services Market Size by Region (2021-2026)
- 1.4.2 Global Peptide Synthesis CDMO Services Market Size by Region (2027-2032)
- 1.5 Key Regions Peptide Synthesis CDMO Services Market Size (2021-2032)
- 1.5.1 North America Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Peptide Synthesis CDMO Services Market Size Growth Rate (2021-2032)
2 Peptide Synthesis CDMO Services Market by Type
- 2.1 Type Introduction
- 2.1.1 GMP Services
- 2.1.2 Non-GMP Services
- 2.2 Global Peptide Synthesis CDMO Services Market Size by Type
- 2.2.1 Global Peptide Synthesis CDMO Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Peptide Synthesis CDMO Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Peptide Synthesis CDMO Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Peptide Synthesis CDMO Services Market Size by Regions
- 2.3.1 North America Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Peptide Synthesis CDMO Services Market Size Breakdown by Type (2021-2026)
3 Peptide Synthesis CDMO Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Commercial
- 3.1.2 Scientific Research
- 3.1.3 Other
- 3.2 Global Peptide Synthesis CDMO Services Market Size by Application
- 3.2.1 Global Peptide Synthesis CDMO Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Peptide Synthesis CDMO Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Peptide Synthesis CDMO Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Peptide Synthesis CDMO Services Market Size by Regions
- 3.3.1 North America Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Peptide Synthesis CDMO Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Peptide Synthesis CDMO Services Industry Trends
- 4.2 Peptide Synthesis CDMO Services Industry Drivers
- 4.3 Peptide Synthesis CDMO Services Industry Opportunities and Challenges
- 4.4 Peptide Synthesis CDMO Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Peptide Synthesis CDMO Services Revenue (2021-2026)
- 5.2 Global Peptide Synthesis CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Peptide Synthesis CDMO Services Key Company Headquarters & Area Served
- 5.4 Global Peptide Synthesis CDMO Services Company, Product Type & Application
- 5.5 Global Peptide Synthesis CDMO Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Peptide Synthesis CDMO Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Peptide Synthesis CDMO Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Peptide Synthesis CDMO Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Bachem
- 6.1.1 Bachem Company Information
- 6.1.2 Bachem Business Overview
- 6.1.3 Bachem Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Bachem Peptide Synthesis CDMO Services Product Portfolio
- 6.1.5 Bachem Recent Developments
- 6.2 CordenPharma
- 6.2.1 CordenPharma Company Information
- 6.2.2 CordenPharma Business Overview
- 6.2.3 CordenPharma Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CordenPharma Peptide Synthesis CDMO Services Product Portfolio
- 6.2.5 CordenPharma Recent Developments
- 6.3 PolyPeptide
- 6.3.1 PolyPeptide Company Information
- 6.3.2 PolyPeptide Business Overview
- 6.3.3 PolyPeptide Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 PolyPeptide Peptide Synthesis CDMO Services Product Portfolio
- 6.3.5 PolyPeptide Recent Developments
- 6.4 AmbioPharm
- 6.4.1 AmbioPharm Company Information
- 6.4.2 AmbioPharm Business Overview
- 6.4.3 AmbioPharm Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 AmbioPharm Peptide Synthesis CDMO Services Product Portfolio
- 6.4.5 AmbioPharm Recent Developments
- 6.5 Genscript
- 6.5.1 Genscript Company Information
- 6.5.2 Genscript Business Overview
- 6.5.3 Genscript Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Genscript Peptide Synthesis CDMO Services Product Portfolio
- 6.5.5 Genscript Recent Developments
- 6.6 Thermo Fisher
- 6.6.1 Thermo Fisher Company Information
- 6.6.2 Thermo Fisher Business Overview
- 6.6.3 Thermo Fisher Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio
- 6.6.5 Thermo Fisher Recent Developments
- 6.7 USV Peptides
- 6.7.1 USV Peptides Company Information
- 6.7.2 USV Peptides Business Overview
- 6.7.3 USV Peptides Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 USV Peptides Peptide Synthesis CDMO Services Product Portfolio
- 6.7.5 USV Peptides Recent Developments
- 6.8 Bio Basic
- 6.8.1 Bio Basic Company Information
- 6.8.2 Bio Basic Business Overview
- 6.8.3 Bio Basic Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Bio Basic Peptide Synthesis CDMO Services Product Portfolio
- 6.8.5 Bio Basic Recent Developments
- 6.9 ScinoPharm
- 6.9.1 ScinoPharm Company Information
- 6.9.2 ScinoPharm Business Overview
- 6.9.3 ScinoPharm Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 ScinoPharm Peptide Synthesis CDMO Services Product Portfolio
- 6.9.5 ScinoPharm Recent Developments
- 6.10 JPT
- 6.10.1 JPT Company Information
- 6.10.2 JPT Business Overview
- 6.10.3 JPT Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 JPT Peptide Synthesis CDMO Services Product Portfolio
- 6.10.5 JPT Recent Developments
- 6.11 CBL
- 6.11.1 CBL Company Information
- 6.11.2 CBL Business Overview
- 6.11.3 CBL Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 CBL Peptide Synthesis CDMO Services Product Portfolio
- 6.11.5 CBL Recent Developments
- 6.12 Piramal Pharma
- 6.12.1 Piramal Pharma Company Information
- 6.12.2 Piramal Pharma Business Overview
- 6.12.3 Piramal Pharma Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio
- 6.12.5 Piramal Pharma Recent Developments
- 6.13 CPC Scientific
- 6.13.1 CPC Scientific Company Information
- 6.13.2 CPC Scientific Business Overview
- 6.13.3 CPC Scientific Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 CPC Scientific Peptide Synthesis CDMO Services Product Portfolio
- 6.13.5 CPC Scientific Recent Developments
- 6.14 Creative Peptides
- 6.14.1 Creative Peptides Company Information
- 6.14.2 Creative Peptides Business Overview
- 6.14.3 Creative Peptides Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Creative Peptides Peptide Synthesis CDMO Services Product Portfolio
- 6.14.5 Creative Peptides Recent Developments
- 6.15 Chinese Peptide Company
- 6.15.1 Chinese Peptide Company Company Information
- 6.15.2 Chinese Peptide Company Business Overview
- 6.15.3 Chinese Peptide Company Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio
- 6.15.5 Chinese Peptide Company Recent Developments
- 6.16 ChengDu ShengNuo Biotec
- 6.16.1 ChengDu ShengNuo Biotec Company Information
- 6.16.2 ChengDu ShengNuo Biotec Business Overview
- 6.16.3 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio
- 6.16.5 ChengDu ShengNuo Biotec Recent Developments
- 6.17 AppTec Co., Ltd.
- 6.17.1 AppTec Co., Ltd. Company Information
- 6.17.2 AppTec Co., Ltd. Business Overview
- 6.17.3 AppTec Co., Ltd. Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio
- 6.17.5 AppTec Co., Ltd. Recent Developments
- 6.18 GL Biochem
- 6.18.1 GL Biochem Company Information
- 6.18.2 GL Biochem Business Overview
- 6.18.3 GL Biochem Peptide Synthesis CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 GL Biochem Peptide Synthesis CDMO Services Product Portfolio
- 6.18.5 GL Biochem Recent Developments
7 North America
- 7.1 North America Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 7.3 North America Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 8.3 Europe Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 10.3 South America Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Peptide Synthesis CDMO Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst